ClinicalTrials.govpublic full text
Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors
liver neoplasm malignant primary, cholangiocarcinoma, combinational immunotherapy, biomarker
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 208456
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.